drugset / Trial / NCT06716151
A Study to Evaluate HB0034 in Healthy Chinese Adult Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to investigate the safety and tolerability of HB0034 in healthy subjects following a single dose or multiple dose.
Timeline
- Start
- 2024-12-06
- Primary completion
- 2025-11-20
- Completion
- 2025-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HB0034 | Monoclonal antibody | — | — |
Indications
No indication recorded.